Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UriTouch appears to be a consumer health and medical-device brand focused on at-home blood uric acid monitoring for people managing gout or elevated uric acid levels. Its main marketed product is a handheld blood uric acid monitoring system with compatible test strips, positioned for home use and sold through e-commerce channels. Public information suggests the brand is closely associated with the gout-focused consumer platform Gout and You, while manufacturing of the underlying device has been linked by FDA records to Visgeneer in Taiwan. The business looks more like a niche commercial diagnostics/device brand than a therapeutics developer, with no evidence of a drug pipeline or clinical-stage biopharma programs. As of 2025, the UriTouch blood uric acid monitoring system was referenced in an FDA Class II recall and in an FDA warning letter involving the manufacturer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UriTouch.